DECIPHER LABS Fact Sheet, DECIPHER LABS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS Fact Sheet    (CMDG)


FREE REPLAY: Catch the Details of Potential Crorepati-Making Stocks Right Now...


Here is the latest financial fact sheet of DECIPHER LABS. For more details, see the DECIPHER LABS quarterly results and DECIPHER LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

DECIPHER LABS Price History

Price Rs 85.4
Mkt Cap Rs m 863
Vol '000 252.9
P/E X 28.1
P/CF X 38.8
EPS (TTM) Rs 3.0
1 Day % -2.8
No. of shares m 10.10
1 Week % -8.1
1 Month % -5.3
1 Year % 138.5
52 week H/L Rs 145.7/27.0
As on Jan 20, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DECIPHER LABS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
DECIPHER LABS EQUITY SHARE DATA
High Rs1227313441 
Low Rs37171618 
Sales per share (Unadj.) Rs0.51.310.123.755.0 
Earnings per share (Unadj.) Rs-0.20.20.51.11.4 
Diluted earnings per shareRs-0.20.20.41.11.4 
Cash flow per share (Unadj.) Rs-0.20.20.51.62.2 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs2.42.73.212.413.6 
Adj. book value per shareRs1.92.12.512.413.6 
Shares outstanding (eoy) m8.008.008.0010.1010.10 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x16.213.72.41.10.5 
Avg P/E ratio x-33.076.447.923.121.3 
P/CF ratio (eoy) x-33.076.447.815.313.4 
Price / Book Value ratio x3.16.67.72.02.2 
Dividend payout %00000 
Avg Mkt Cap Rs m61139194254298 
No. of employees `000NANANANANA 
Total wages/salary Rs m1210193473 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
DECIPHER LABS INCOME DATA
Net Sales Rs m41081240556 
Other income Rs m01036 
Total revenues Rs m41181243562 
Gross profit Rs m-2142535 
Depreciation Rs m00068 
Interest Rs m000812 
Profit before tax Rs m-2241521 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m00047 
Profit after tax Rs m-2241114 
Gross profit margin %-49.26.85.610.56.3 
Effective tax rate %008.024.934.5 
Net profit margin %-49.218.05.04.62.5 
DECIPHER LABS BALANCE SHEET DATA
Current assets Rs m43063227225 
Current liabilities Rs m6838213173 
Net working cap to sales %-62.3208.431.05.69.4 
Current ratio x0.63.51.71.11.3 
Inventory Days Days2,1601111777 
Debtors Days Days1322111,5662,224766 
Net fixed assets Rs m2200127161 
Share capital Rs m808080101101 
"Free" reserves Rs m-61-59-552536 
Net worth Rs m192125126137 
Long term debt Rs m000067 
Total assets Rs m263063353387 
Interest coverage xNMNM74.52.92.8 
Debt to equity ratio x00000.5 
Sales to assets ratio x0.10.31.30.71.4 
Return on assets %-7.26.26.55.36.7 
Return on equity %-9.58.616.08.810.2 
Return on capital %-9.38.617.717.816.2 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
DECIPHER LABS CASH FLOW
From Operations Rs m 0 -1 2 -152 18 
From Investments Rs m 0 0 0 -1 -3 
From Financial Activity Rs m 0 1 1 164 40 
Net Cashflow Rs m 0 0 3 12 55 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 45.9%
Institution 0.0%
Non-Institution 54.1%
Total 100.0%
Free Float 54.1%
Pledged promoter holdings 0.0%
Shareholding as on Sep 2021
 

Company Information

Regd Off Plot No. 94 4th Floor, Road No. 2 Sagar Society, Banjara Hills, Hyderabad - 500034
E-mail info@decipherlabs.in Web www.dechipherlabs.in
Tel 040-48536100 Fax
Sector PHARMACEUTICALS Group MNC
Tr Agent Venture Capital & Corporate Investments Ltd, 12-10-167, MIG- 167, Bharat Nagar Colony
YEAR OF INC: 1986 BSE CODE: 524752 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare DECIPHER LABS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks Views On News (Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DECIPHER LABS

  • Track your investment in DECIPHER LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DECIPHER LABS

DECIPHER LABS - ADCOCK INGRAM COMPARISON

COMPARE DECIPHER LABS WITH

MARKET STATS